Castle Biosciences Inc.
CSTL | NASDAQ
$34.99
-$0.35 (-0.99%)
At close: Sep 21, 2026, 4:00 PM ET
$34.99
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 344.23M | 332.07M | 219.79M | 137.04M | 94.09M | 62.65M |
Cost of Revenue | 71.03M | 60.21M | 44.98M | 32.01M | 15.82M | 9.69M |
Gross Profit | 273.2M | 271.86M | 174.81M | 105.03M | 78.26M | 52.96M |
Operating Income | -42.81M | 8.67M | -67.98M | -72.86M | -40.08M | -6.54M |
Interest Income | 11.77M | 12.92M | 10.62M | 3.97M | 68K | 373K |
Pretax Income | -29.51M | 21.56M | -57.37M | -68.9M | -40.01M | -10.2M |
Net Income | -24.16M | 18.25M | -57.47M | -67.14M | -31.29M | -10.28M |
Selling & General & Admin | 229.32M | 200.05M | 180.15M | 143M | 86.74M | 48.13M |
Research & Development | 51.85M | 52.04M | 53.62M | 44.9M | 29.65M | 13.26M |
Other Expenses | 34.84M | 11.11M | 9.01M | -10.02M | 1.96M | -1.88M |
Operating Expenses | 316.01M | 263.19M | 242.78M | 177.89M | 118.34M | 59.51M |
Interest Expense | 86K | 577K | 11K | 17K | 1K | 2.63M |
Selling & Marketing Expenses | 138.12M | 123.47M | 113.66M | 86.61M | n/a | n/a |
Cost & Expenses | 387.04M | 323.4M | 287.77M | 209.89M | 134.16M | 69.19M |
Income Tax Expense | -5.36M | 3.32M | 101K | -1.77M | -8.72M | 84K |
Shares Outstanding (Basic) | 28.99M | 27.78M | 26.8M | 26.05M | 25.14M | 18.93M |
Shares Outstanding (Diluted) | 28.99M | 29.26M | 26.8M | 26.05M | 25.14M | 18.93M |
EPS (Basic) | -0.83 | 0.66 | -2.14 | -2.58 | -1.24 | -0.54 |
EPS (Diluted) | -0.83 | 0.62 | -2.14 | -2.58 | -1.24 | -0.54 |
EBITDA | 11.34M | 38.14M | -45.02M | -58.34M | -36.6M | -7.09M |
EBIT | -29.43M | 22.14M | -57.35M | -68.89M | -40.01M | -7.57M |
Depreciation & Amortization | 40.77M | 16M | 12.33M | 10.54M | 3.41M | 472K |
Add to Watchlist
Select watchlists to add or remove CSTL